Company Profile
Stryker Stock Price, News & Analysis
- Ticker:
- SYK
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Stryker is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
310.00 USD (+1.74%)
Close
Last updated: June 23, 2026 at 00:00
118.84B USD
Market cap
Why the stock is moving
SYK is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Stryker is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Stryker is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Stryker follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Stryker sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Stryker reports 2025 operating results and 2026 outlook
Source: Stryker
- 04
Stryker declares an $0.88 per share quarterly dividend
Source: Stryker
- 05
Stryker announces Annual Meeting of Shareholders
Source: Stryker
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Stryker (SYK)?
Stryker (SYK) most recently closed at 310.00 USD, a +1.74% move versus the previous session.
What is the market cap of Stryker (SYK)?
Stryker currently has a market capitalization of 118.84B USD on BioPharmSignal.
What does Stryker do?
Stryker is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is SYK stock listed?
Stryker (SYK) is associated with NYSE, Headquartered in the United States and listed on NYSE, Stryker is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Stryker?
Stryker is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Stryker targeting with Stryker?
Stryker is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.